(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Philip Frost, Chairman and CEO of OPKO Health, on the current landscape for the biotech industry, the company product pipeline, and drug pricing.

Warsh Says Inflation Isn’t Slowing, Vows to Reach 2% Target
15:10

Salesforce Jumps Most Since 2020 on Outlook, Anthropic Deal
21:35

Meta Says It Will Pay Up to $18 Billion Over Social Media Claims
25:02